Instil Bio
32 hedge funds and large institutions have $34.6M invested in Instil Bio in 2026 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
29% less capital invested
Capital invested by funds: $48.9M → $34.6M (-$14.3M)
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
Holders
32
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$1.48M | |
| 2 | +$113K | |
| 3 | +$93.4K | |
| 4 |
PCM
Prelude Capital Management
New York
|
+$83.6K |
| 5 |
VAM
Vazirani Asset Management
New York
|
+$81.1K |
Top Sellers
| 1 | -$2.24M | |
| 2 | -$891K | |
| 3 | -$561K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$333K |
| 5 |
QC
Quadrature Capital
London,
United Kingdom
|
-$211K |
